Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2018 Apr 16;3(4):1010-1014.
doi: 10.1016/j.ekir.2018.04.003. eCollection 2018 Jul.

Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism

Sidharth Kumar Sethi  1 , Shyam Bihari Bansal  1 , Nikita Wadhwani  1 , Mayur Makasana  1 , Ashish Nandwani  1 , Vijay Kher  1 , Rupesh Raina  2
Affiliations
Case Reports

Myelofibrosis-Induced Erythropoietin-Resistant Anemia Due to Severe Refractory Hyperparathyroidism

Sidharth Kumar Sethi et al. Kidney Int Rep. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Diffuse osteopenia and rickets in long bones (a). Radiological and histologic findings in case 1 (b). A well-defined heterogeneously hyperechoic round lesions in the parathyroid suggestive of parathyroid hyperplasia or adenoma (c). A bone marrow biopsy showing hypocellularity and prominent resorption bays (Howship lacunae). Increased reticulin deposition and myelofibrosis (World Health Organization myelofibrosis grade 2) with paratrabecular accentuation evident on Masson trichome staining (d).
Figure 2
Figure 2
Radiological features of long bones of patient 2. (a) Severe rickets, diffuse osteopenia of long bones, and (b) diffuse osteopenia in pseudofractures in the tibia and fibula.
See this image and copyright information in PMC

References

    1. Oliveira R.B., Cancela A.L., Graciolli F.G. Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy? Clin J Am Soc Nephrol. 2010;5:286–291. - PMC - PubMed
    1. Sliem H., Tawfik G., Moustafa F., Zaki H. Relationship of associated secondary hyperparathyroidism to serum fibroblast growth factor-23 in end stage renal disease: a case-control study. Indian J Endocrinol Metab. 2011;15:105–109. - PMC - PubMed
    1. Trovato G.M., Iannetti E., Carpinteri G. Systolic function impairment in higher erythropoietin requirement patients in hemodialysis. Recenti Prog Med. 1997;88:217–222. - PubMed
    1. Wu S.G., Jeng F.R., Wei S.Y. Red blood cell osmotic fragility in chronically hemodialyzed patients. Nephron. 1998;78:28–32. - PubMed
    1. Meytes D., Bogin E., Ma A. Effect of parathyroid hormone on erythropoiesis. J Clin Invest. 1981;67:1263–1269. - PMC - PubMed

Publication types

LinkOut - more resources